BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26634385)

  • 21. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
    Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells.
    Matai I; Sachdev A; Gopinath P
    Biomater Sci; 2015 Mar; 3(3):457-68. PubMed ID: 26222289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs.
    Dinicola S; Morini V; Coluccia P; Proietti S; D'Anselmi F; Pasqualato A; Masiello MG; Palombo A; De Toma G; Bizzarri M; Cucina A
    Toxicol In Vitro; 2013 Dec; 27(8):2256-63. PubMed ID: 24095863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
    Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
    J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-fluorouracil-loaded polydioxanone weft-knitted stent for the treatment of colorectal cancer.
    Li G; Chen Y; Hu J; Wu X; Hu J; He X; Li J; Zhao Z; Chen Z; Li Y; Hu H; Li Y; Lan P
    Biomaterials; 2013 Dec; 34(37):9451-61. PubMed ID: 24011711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
    Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
    J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer.
    Tummala S; Satish Kumar MN; Prakash A
    Saudi Pharm J; 2015 Jul; 23(3):308-14. PubMed ID: 26106279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efficacy of 5-fluorouracil in combination with a dual histone deacetylase and phosphatidylinositide 3-kinase inhibitor (CUDC-907) in colorectal cancer cells.
    Hamam R; Ali D; Vishnubalaji R; Alsaaran ZF; Chalisserry EP; Alfayez M; Aldahmash A; Alajez NM
    Saudi J Gastroenterol; 2017; 23(1):34-38. PubMed ID: 28139498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer effects of 2-oxoquinoline derivatives on the HCT116 and LoVo human colon cancer cell lines.
    Fang FQ; Guo HS; Zhang J; Ban LY; Liu JW; Yu PY
    Mol Med Rep; 2015 Dec; 12(6):8062-70. PubMed ID: 26498992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.
    Zeng ZL; Luo HY; Yang J; Wu WJ; Chen DL; Huang P; Xu RH
    Clin Cancer Res; 2014 Feb; 20(4):1042-52. PubMed ID: 24277452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gap junction composed of connexin43 modulates 5‑fluorouracil, oxaliplatin and irinotecan resistance on colorectal cancers.
    Zou ZW; Chen HJ; Yu JL; Huang ZH; Fang S; Lin XH
    Mol Med Rep; 2016 Nov; 14(5):4893-4900. PubMed ID: 27748862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.
    Zhao C; Qiu S; He J; Peng Y; Xu H; Feng Z; Huang H; Du Y; Zhou Y; Nie Y
    Cancer Lett; 2020 Jul; 481():15-23. PubMed ID: 32184145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan-Coated Cinnamon/Oregano-Loaded Solid Lipid Nanoparticles to Augment 5-Fluorouracil Cytotoxicity for Colorectal Cancer: Extract Standardization, Nanoparticle Optimization, and Cytotoxicity Evaluation.
    Kamel KM; Khalil IA; Rateb ME; Elgendy H; Elhawary S
    J Agric Food Chem; 2017 Sep; 65(36):7966-7981. PubMed ID: 28813148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway.
    Su M; Qin B; Liu F; Chen Y; Zhang R
    Drug Des Devel Ther; 2017; 11():3333-3341. PubMed ID: 29200829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods of overcoming treatment resistance in colorectal cancer.
    Temraz S; Mukherji D; Alameddine R; Shamseddine A
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):217-30. PubMed ID: 24075059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay.
    Alami N; Paterson J; Belanger S; Juste S; Grieshaber CK; Leyland-Jones B
    J Chemother; 2007 Oct; 19(5):546-53. PubMed ID: 18073154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA).
    Cho YB; Lee WY; Song SY; Choi SH; Shin HJ; Ahn KD; Lee JM; Kim HC; Yun SH; Chun HK
    Eur J Surg Oncol; 2009 Sep; 35(9):951-6. PubMed ID: 19181477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.